Effects of vedolizumab, adalimumab and infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease

C. S. Tse, E. V. Loftus, L. E. Raffals, A. A. Gossard, A. L. Lightner

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Fingerprint Dive into the research topics of 'Effects of vedolizumab, adalimumab and infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease'. Together they form a unique fingerprint.

Medicine & Life Sciences